Boston Scientific Reports Positive HI-PEITHO Trial Data for EKOS System

News Image
Read full story

Published: 2 hours ago

Boston Scientific announced positive results from its HI-PEITHO global randomized clinical trial, showing the EKOS Endovascular System's superiority in treating intermediate-risk pulmonary embolism patients. The news may provide minor support for USD as positive healthcare sector developments can boost investor confidence in US equities and the dollar, though impact is limited given the specialized nature of the medical device.

Nothing to see yet 😢